A focus on heme oxygenase-1 (HO-1) inhibitors

Current Medicinal Chemistry

Volumn 20, Issue 30, 2013, Pages 3711-3732

  Pittala V ^a   Salerno, L ^a   Romeo, G ^a   Modica, M N ^a   Siracusa, M A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antitumoral; Heme oxygenase; Heme oxygenase inducers; Heme oxygenase inhibitors; HO 1; HO 2; Imidazoledioxolane derivatives; Imidazoles

Indexed keywords

AZALANSTAT; BILIVERDIN; CARBON MONOXIDE; CHLOROQUINE; DELMITIDE; FERROUS ION; HEME OXYGENASE 1 INHIBITOR; HEME OXYGENASE INHIBITOR; IMIDAZOLE DERIVATIVE; ISOCONAZOLE; KETOCONAZOLE; METALLOPORPHYRIN; MICONAZOLE; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN ZINC; STANNSOPORFIN; SULCONAZOLE; TERCONAZOLE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CASTRATION RESISTANT PROSTATE CANCER; CATABOLISM; CELL PROTECTION; CRYSTAL STRUCTURE; DIABETES MELLITUS; HUMAN; HYDROGEN BOND; HYPERBILIRUBINEMIA; HYPOXIA; IC 50; IMMUNOMODULATION; INFLAMMATION; ISCHEMIA; NEUROMODULATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PLASMODIUM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UPREGULATION;

EID: 84883336320     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320300003     Document Type: Article

References (119)

1. Tenhunen, R.; Marver, H.S.; Schmid, R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA, 1968, 61, 748-755.
2. Maines, M.D.; Abraham, N.G.; Kappas, A. Solubilization and partial purification of heme oxygenase from rat liver. J. Biol. Chem., 1977, 252, 5900-5903.
3. Yoshida, T.; Kikuchi, G. Purification and properties of heme oxygenase from pig spleen microsomes. J. Biol. Chem., 1978, 253, 4224-4229.
4. Yoshinaga, T.; Sassa, S.; Kappas, A. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J. Biol. Chem., 1982, 257, 7778-7785.
5. Abraham, N.G.; Lin, J.H.; Dunn, M.W.; Schwartzman, M.L. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Invest. Ophthalmol. Vis. Sci., 1987, 28, 1464-1472.
6. Hayashi, S.; Omata, Y.; Sakamoto, H.; Higashimoto, Y.; Hara, T.; Sagara, Y.; Noguchi, M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene, 2004, 336, 241-250.
7. McCoubrey, W.K. Jr.; Maines, M.D. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2. Gene, 1994, 139, 155-161.
8. Mancuso, C.; Barone, E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr. Drug Metab., 2009, 10, 579-594.
9. Abraham, N.G.; Kappas, A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev., 2008, 60, 79-127.
10. Ferrandiz, M.L.; Devesa, I. Inducers of heme oxygenase-1. Curr. Pharm. Des., 2008, 14, 473-486.
11. Immenschuh, S.; Ramadori, G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem. Pharmacol., 2000, 60, 1121-1128.
12. Ishizaka, N.; Griendling, K.K. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension, 1997, 29, 790-795.
13. Takahashi, K.; Nakayama, M.; Takeda, K.; Fujita, H.; Shibahara, S. Suppression of heme oxygenase-1 mRNA expression by interferongamma in human glioblastoma cells. J. Neurochem., 1999, 72, 2356-2361.
14. Pellacani, A.; Wiesel, P.; Sharma, A.; Foster, L.C.; Huggins, G.S.; Yet, S-F.; Perrella, M.A. Induction of heme oxygenase-1 during endotoxemia is down-regulated by transforming growth factor-b1. Circ. Res., 1998, 83, 396-403.
15. Immenschuh, S.; Stritzke, J.; Iwahara, S-I.; Ramadori, G. Upregulation of heme-binding protein 23 (HBP23) gene expression by lipopolysaccharide is mediated via a nitric oxide-dependent signaling pathway in rat Kupffer cells. Hepatology, 1999, 30, 118-127.
16. Zhao, H.; Wong, R.J.; Nguyen, X.; Kalish, F.; Mizobuchi, M.; Vreman, H.J.; Stevenson, D.K.; Contag, C.H. Expression and regulation of heme oxygenase isozymes in the developing mouse cortex. Pediatric Res., 2006, 60, 518-523.
17. Miyazaki, T.; Kirino, Y.; Takeno, M.; Samukawa, S.; Hama, M.; Tanaka, M.; Yamaji, S.; Ueda, A.; Tomita, N.; Fujita, H.; Ishigatsubo, Y. Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1. Cancer Sci., 2010, 101, 1409-1416.
18. Zhang, X.; Shan, P.; Jiang, D.; Noble, P.W.; Abraham, N.G.; Kappas, A.; Lee, P.J. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem., 2004, 279, 10677-10684.
19. Yachie, A.; Niida, Y.; Wada, T.; Igarashi, N.; Kaneda, H.; Toma, T.; Ohta, K.; Kasahara, Y.; Koizumi, S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest., 1999, 103, 129-135.
20. Ryter, S.W.; Alam J.; Choi A.M.K. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev., 2006, 86, 583-650.
21. Motterlini, R.; Otterbein, L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Disc., 2010, 9, 728-743.
22. Jansen, T.; Daiber, A. Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase? Front. Pharmacol., 2012, 3, 1-10.
23. Sedlak, T.W.; Saleh, M.; Higginson, D.S.; Paul, B.D.; Juluri, K.R.; Snyder, S.H. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. USA, 2009, 106, 5171-5176.
24. Lloyd, R.V.; Hanna, P.M.; Mason, R.P. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic. Biol. Med., 1997, 22, 885-888.
25. Ferris, C.D.; Jaffrey, S.R.; Sawa, A.; Takahashi, M.; Brady, S.D.; Barrow, R.K.; Tysoe, S.A.; Wolosker, H.; Barañano, D.E.; Doré, S.; Poss, K.D.; Snyder, S.H. Heme oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell. Biol., 1999, 1, 152-157.
26. Gozzellino, R.; Jeney, V.; Soares, M.P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol., 2010, 50, 323-354.
27. Bucolo, C.; Drago, F. Focus on molecules: Hemeoxygenase-1. Exp. Eye Res., 2009, 89, 822-823.
28. Bucolo, C.; Drago, F. Carbonmonoxide and the eye: Implications for glaucoma therapy. Pharmacol. Ther., 2011, 130, 191-201.
29. Stagni, E.; Privitera, M.G.; Bucolo, C.; Leggio, G.M.; Motterlini, R.; Drago, F. A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits. Br. J. Ophthalmol., 2009, 93, 254-257.
30. Platt, J.L.; Nath, K.A. Heme oxygenase: protective gene or Trojan horse. Nat. Med. 1998, 4, 1364-1365.
31. Granchi, S.; Minutolo, F. Anticancer that counteract tumor glycolysis. ChemMedChem., 2012, 7, 1318-1350.
32. Bindi, S.; Fancelli, D.; Alli, C.; Berta, D.; Bertrand, J.A.; Cameron, A.D.; Cappella, P.; Carpinelli, P.; Cervi, G.; Croci, V.; D'Anello, M.; Forte, B.; Giorgini, L.M.; Marsiglio, A.; Moll, J.; Pesenti, E.; Pittalà, V.; Pulici, M.; Riccardi-Sirtori, F.; Roletto, F.; Soncini, C.; Storici, P.; Varasi, M.; Volpi, D.; Zugnoni, P.; Vianello, P. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity. Bioorg. Med. Chem., 2010, 18, 7113-7120.
33. Pevarello, P.; Fancelli, D.; Vulpetti, A.; Amici, R.; Villa, M.; Pittalà, V.; Vianello, P.; Cameron, A.; Ciomei, M.; Mercurio, C.; Bischoff, J.R.; Roletto, F.; Varasi, M.; Brasca, M.G. 3-Amino-1,4,5,6- tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 1084-1090.
34. Fancelli, D.; Berta, D.; Bindi, S.; Cameron, A.; Cappella, P.; Carpinelli, P.; Catana, C.; Forte, B.; Giordano, P.; Giorgini, M.L.; Mantegani, S.; Marsiglio, A.; Meroni, M.; Moll, J.; Pittalà, V.; Roletto, F.; Severino, D.; Soncini, C.; Storici, P.; Tonani, R.; Varasi, M.; Vulpetti, A.; Vianello, P. Potent and selective aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition. J. Med. Chem., 2005, 48, 3080-3084.
35. Fortuna, C.G.; Forte, G.; Pittalà, V.; Giuffrida, A.; Consiglio, G. Could 2,6-bis((E)-2-(furan-2-yl)vinyl)-1-methylpyridinium iodide and analog compounds intercalate DNA? A first principle prediction based on structural and electronic properties. Comp. Theor. Chem., 2012, 985, 8-13.
36. Was, A.; Dulak, J.; Jozkowicz, A. Heme oxygenase-1 in tumor biology and therapy. Curr. Drug. Targ., 2010, 11, 1551-1570.
37. Kinobe R.T; Dercho R.A; Nakatsu K. Inhibitors of the heme oxygenase-carbon monoxide system: on the doorstep of the clinic. Can. J. Physiol. Pharmacol., 2008, 86, 577-599.
38. Mayerhofer, M.; Florian, S.; Krauth, M.T.; Aichberger, K.J.; Bilban, M.; Marculescu, R.; Printz, D.; Fritsch, G.; Wagner, O.; Selzer, E.; Sperr, W.R.; Valent, P.; Sillaber, C. Identification of hemoxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res., 2004, 64, 3148-3154.
39. Sass, G.; Leukel, P.; Schmitz, V.; Raskopf, E.; Ocker, M.; Neureiter, D.; Meissnitzer, M.; Tasika, E.; Tannapfel, A.; Tiegs, G. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int. J. Cancer, 2008, 123, 1269-1277.
40. Liu, Z.M.; Chen, G.G.; Ng, E.K.; Leung, W-K.; Sung, J.J.Y.; Chung, S.C.S. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene, 2004, 23, 503-513.
41. Busserolles, J.; Megias, J.; Terencio, M.C.; Alcaraz, M.J. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int. J. Biochem. Cell. Biol., 2006, 38, 1510-1517.
42. Sunamura, M.; Duda, D.G.; Ghattas, M.H.; Lozonschi, L.; Motoi, F.; Yamauchi, J.I.; Matsuno, S.; Shibahara, S.; Abraham, N.G. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis, 2003, 6, 15-24.
43. Woo-Kwang, J.; Hey-Young, H.; Won-Chan, S.; Kyu-Hyoung, L.; Hui-Young, L.; Woo-Jin, K.; Seo-Young, S.; Byung-Chul, K. Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition. Biochem. Biophys. Res. Commun., 2012, 420, 288-292.
44. Miyake, M.; Fujimoto, K.; Anai, S.; Ohnishi, S.; Nakai, Y.; Inoue, T.; Matsumura, Y.; Tomioka, A.; Ikeda, T.; Okajima, E.; Tanaka, N.; Hirao, Y. Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. Anticancer Res., 2010, 30, 2145-2152.
45. Zhang, W.; Qiao, T.; Zha, L. Inhibition of heme oxygenase-1 enhances the radiosensitivity in human nonsmall cell lung cancer A549 cells. Cancer Biother. Radio. 2011, 26, 639-645.
46. Nowis, D.; Legat, M.; Grzela, T.; Niderla, J.; Wilczek, E.; Wilczynski, G.M.; Glodkowska, E.; Mrowka, P.; Issat, T.; Dulak, J.; Jozkowicz, A.; Was, H.; Adamek, M.; Wrzosek, A.; Nazarewski, S.; Makowski, M.; Stoklosa, T.; Jakobisiak, M.; Golab, J. Heme oxygenase-1 protects tumor cells against photodynamic therapymediated cytotoxicity. Oncogene, 2006, 25, 3365-3374.
47. Frank, J.; Lornejad-Schaefer, M.R.; Schoeffl, H.; Flaccus, A.; Lambert, C.; Biesalski, H.K. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int. J. Oncol., 2007, 31, 1539-1545.
48. Marinissen, M.J.; Tanos, T.; Bolos, M.; De Sagarra, M.R.; Coso, O.A.; Cuadrado, A. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirusencoded G protein-coupled receptor. J. Biol. Chem., 2006, 281, 11332-11346.
49. Hirai, K.; Sasahira, T.; Ohmori, H.; Fujii, K.; Kuniyasu, H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int. J. Cancer, 2007, 120, 500-505.
50. Shi, L.; Fang, J. Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy. J. Exp. Clin. Cancer Res., 2008, 27, 13.
51. Fang, J.; Sawa, T.; Akaike, T.; Greish, K.; Maeda, H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int. J. Cancer, 2004, 109, 1-8.
52. Fang, J.; Greish, K.; Qin, H.; Liao, L.; Nakamura, H.; Takeya, M.; Maeda, H. HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water soluble micelle as anticancer agent: in vitro and in vivo anticancer effect. Eur. J. Pharm. Biopharm., 2012, 81, 540-547.
53. Shan, Y.; Pepe, J.; Lu, T.H.; Elbirt, K.K.; Lambrecht, R.W.; Bonkovsky, H.L. Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch. Biochem. Biophys., 2000, 380, 219-227.
54. Wong, R.J.; Vreman, H.J.; Schulz, S.; Kalish, F.S.; Pierce, N.W.; Stevenson, D.K. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins. J. Perinat., 2011, 31, S35-S41.
55. Gazzin, S.; Tiribelli, C. Bilirubin-induced neurological damage. J. Matern-Fetal Neonat. Med., 2011, 24, 154-155.
56. Schwartz, H.P.; Haberman B.E.; Ruddy R.M. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr. Emerg. Care, 2011, 27, 884-889.
57. Stevenson, D.K.; Wong, R.J. Metalloporphyrins in the management of neonatal hyperbilirubinemia. Sem. Fetal Neonat. Med. 2010, 15, 164-168.
58. Morisawa, T.; Wong, R.J.; Bhutani, V.K.; Vreman, H.J.; Stevenson, D.K. Inhibition of heme oxygenase activity in newborn mice by azalanstat. Can. J. Physiol. Pharmacol., 2008, 86, 651-659.
59. Zhu, W.; Wilks, A.; Stojiljkovic, I. Degradation of heme in gramnegative bacteria: the product of the hemO gene of Neisseriae is a heme oxygenase. J. Bacterial., 2000, 182, 6783-6790.
60. Skaar, E.P.; Gaspar, A.H.; Scneewind, O. IsdG and IsdI, hemedegrading enzymes in the cytoplasm of Staphylococcus aureus. J. Biol. Chem., 2004, 279, 436-443.
61. Wegele, R.; Tasler, R.; Zeng, Y.; Rivera, M.; Frankenberg-Dinkel, N. The heme oxygenase(s)-phytochrome system of Pseudomonas aeruginosa. J. Biol. Chem., 2004, 279, 45791-45802.
62. Suits, M.D.; Pal, G.P.; Nakatsu, K.; Matte, A.; Cygler, M.; Jia, Z. Identification of an Escherichia coli O157:H7 heme oxygenase with tandem functional repeats. Proc. Natl. Acad. Sci. USA, 2005, 102, 16955-16960.
63. Braun, V. Iron uptake mechanisms and their regulation in pathogenic bacteria. Int. J. Med. Microbiol., 2001, 291, 67-79.
64. Wandersman, C.; Stojiljkovic, I. Bacterial heme sources: the role of heme, hemoprotein receptors and hemophores. Curr. Opin. Microbiol., 2000, 3, 215-220.
65. Wilks, A. Heme oxygenase: evolution, structure, and mechanism. Antioxid. Redox Signaling, 2002, 4, 603-614.
66. Srivastava, P. Heme metabolism: an innovative approach to harness resistance malaria. Nat. Acad. Sci. Lett., 2004, 27, 387-393.
67. Navarathna, D.H.M.L.P.; Roberts, D.D. Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expression. Free Radic. Biol. Med., 2010, 49, 1561-1573.
68. Chung, S.W.; Hall, S.R.; Perrella, M.A. Role of heme oxygenase-1 in microbial host defense. Cell. Microbiol., 2009, 11, 199-207.
69. Chung, S.W.; Liu, X.; Macias, A.A.; Baron, R.M.; Perrella, M.A. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J. Clin. Invest., 2008, 118, 239-247.
70. Kappas, A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics, 2004, 113, 119-123.
71. Ny, L.; Andersson, K.E.; Grundemar, L. Inhibition by zinc protoporphyrin-IX of receptor-mediated relaxation of the rat aorta in a manner distinct from inhibition of heme oxygenase. Br. J. Pharmacol., 1995, 115, 186-190.
72. Iyer, S.; Woo, J.; Cornejo, M.C.; Gao, L.; McCoubrey, W.; Maines, M.; Buelow, R. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E 3 V) binding protein. Isolation of heme oxygenase-1. J. Biol. Chem., 1998, 273, 2692-2697.
73. Cuturi, M.C.; Christoph, F.; Woo, J.; Iyer, S.; Brouard, S.; Heslan, J.M.; Pignon, P.; Soulillou, J.P.; Buelow, R. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol. Med., 1999, 5, 820-832.
74. Jung, N.H.; Kim, H.P.; Kim, B.R.; Cha, S.H.; Kim, G.A.; Ha, H.; Na, Y.E.; Cha, Y.N. Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life, 2003, 55, 525-532.
75. Kim, H.P.; Wang, X.; Galbiati, F.; Ryter, S.W.; Choi, A.M. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J., 2004, 18, 1080-1089.
76. Couet, J.; Li, S.; Okamoto, T.; Ikezu, T.; Lisanti, M.P. Identification of peptide and protein ligands for the caveolin scaffolding domain. Implications for the interaction of caveolin with caveolaeassociated proteins. J. Biol. Chem., 1997, 272, 6525-6533.
77. Taira, J.; Sugishima, M.; Kida, Y.; Oda, E.; Noguchi, M.; Higashimoto, Y. Caveolin-1 is a competitive inhibitor of heme oxygenase-1 (HO-1) with heme: identification of a minimum sequence in caveolin-1 for binding to HO-1. Biochem., 2011, 50, 6824-6831.
78. Walker, K.A.M.; Kertesz, D.J.; Rotstein, D.M.; Swinney, D.C.; Berry, P.W.; So, O.Y.; Webb, A.S.; Watson, D.M.; Mak, A.Y.; Burton, P.M.; Mills-Dunlap, B.; Chiou, M.Y.; Tokes, L.G.; Kurz, L.J.; Kern, J.R.; Chan, K.W.; Salari, A.; Mendizabal, G.R. Selective inhibition of mammalian lanosterol 14α-demethylase: a possible strategy for cholesterol lowering. J. Med. Chem., 1993, 36, 2235-2237.
79. Vreman, H.J.; Wong, R.J.; Stevenson, D.K. In carbon monoxide and cardiovascular function; Wang, R., Ed.; CRC: Boca Raton, 2002, Chapter 15, 273.
80. Vlahakis, J.Z.; Kinobe, R.T.; Bowers, R.J.; Brien, J.F.; Nakatsu, K.; Szarek, W.A. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors. Bioorg. Med. Chem. Lett., 2005, 15, 1457-1461.
81. Vlahakis, J.Z.; Kinobe, R.T.; Bowers, R.J.; Brien, J.F.; Nakatsu, K.; Szarek, W.A. Imidazole-dioxolane compounds as isozymeselective heme oxygenase inhibitors. J. Med. Chem., 2006, 49, 4437-4441.
82. Kinobe, R.T.; Vlahakis, J.Z.; Vreman, H.J.; Stevenson, D.K.; Brien, J.F.; Szarek, W.A.; Nakatsu, K. Selectivity of imidazoledioxolane compounds for in vitro inhibition of microsomal hem oxygenase isoforms. Br. J. Pharmacol., 2006, 147, 307-315.
83. Kinobe, R.T.; Ji, Y.; Vlahakis, J.Z.; Motterlini, R.; Brien, J.F.; Szarek, W.A.; Nakatsu, K. Effectiveness of novel imidazoledioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells. J. Pharmacol. Exp. Ther., 2007, 323, 763-770.
84. Balogun, E.; Foresti, R.; Green, C.J.; Motterlini, R. Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells. Biochem. Biophys. Res. Commun., 2003, 308, 950-955.
85. Csongradi, E.; Vera, T.; Rimoldi, J.M.; Gadepalli, R.S.V.; Stec, D.E. In vivo inhibition of renal heme oxygenase with an imidazoledioxolane inhibitor. Pharmacol. Res., 2010, 61, 525-530.
86. Csongradi, E.; Storm, M.V.; Stec, D.E. Renal inhibition of heme oxygenase-1 increases blood pressure in angiotensin II-dependent hypertension. Int. J. Hypertens., 2012, 497213, 1-8.
87. Dixon, S.C.; Zalles, A.; Giordano, C.; Lush, R.M.; Venzon, D.; Reed, E.; Figg, W.D. In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3. Cancer Lett., 1997, 113, 111-116.
88. Wilkinson, S.; Chodak, G. An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer. Eur. Urol., 2004, 45, 581-585.
89. Kinobe, R.T.; Dercho, R.A.; Vlahakis, J.Z.; Brien, J.F; Szarek, W.A.; Nakatsu, K. Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs. J. Pharmacol. Exp. Ther., 2006, 319, 277-284.
90. Roman, G.; Riley, J.G.; Vlahakis, J.Z.; Kinobe, R.T.; Brien, J.F.; Nakatsu, K.; Szarek, W.A. Heme oxygenase inhibition by 2-oxysubstituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring. Bioorg. Med. Chem., 2007, 15, 3225-3234.
91. Alaoui-Jamali, M.A.; Bismar, T.A.; Gupta, A.; Szarek, W.A.; Su, J.; Song, W.; Xu, Y.; Xu, B.; Guoan, L., Vlahakis, J.Z.; Roman, G.; Jiao, J.; Schipper, H.M. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res., 2009, 69, 8017-8024.
92. Di Francesco, L.; Totani, L.; Dovizio, M.; Piccoli, A.; Di Francesco, A.; Salvatore, T.; Pandolfi, A.; Evangelista, V.; Dercho, R.A.; Seta, F.; Patrignani, P. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-α biosynthesis via heme oxygenase-1 in human endothelial cells. Circ. Res., 2009, 104, 506-551.
93. Hum, M.; McLaughlin, B.E.; Roman, G.; Vlahakis, J.Z.; Szarek, W.A.; Nakatsu, K. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6. J. Pharmacol. Exp. Ther., 2010, 334, 981-987.
94. Sugishima, M.; Higashimoto, Y.; Oishi, T.; Takahashi, H.; Sakamoto, H.; Noguchi, M.; Fukuyama, K. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase. Biochem., 2007, 46, 1860-1867.
95. Omata, Y.; Asada, S.; Sakamoto, H.; Fukuyama, K.; Noguchi, M. Crystallization and preliminary X-ray diffraction studies on the water soluble form of rat heme oxygenase-1 in complex with heme. Acta Crystallogr. D, 1998, 54, 1017-1019.
96. Sugishima, M.; Omata, Y.; Kakuta, Y.; Sakamoto, H.; Noguchi, M.; Fukuyama, K. Crystal structure of rat heme oxygenase-1 in complex with heme. FEBS Lett., 2000, 471, 61-66.
97. Schuller, D.J.; Wilks, A.; De Montellano, P.O.; Poulos, T.L. Crystallization of recombinant human heme oxygenase-1. Protein Sci., 1998, 7, 1836-1838.
98. Schuller, D.J.; Wilks, A.; De Montellano, P.R.O.; Poulos, T.L. Crystal structure of human heme oxygenase-1 Nat. Struct. Biol., 1999, 6, 860-867.
99. Lad, L.; Schuller, D.J.; Shimizu, H.; Friedman, J.; Li, H.; De Montellano, O.P.R.; Poulos, T.L. Comparison of the heme-free and - bound crystal structures of human heme oxygenase-1. J. Biol. Chem., 2003, 278, 7834-7843.
100. Rahman, M.N.; Vlahakis, J.Z.; Szarek, W.A.; Nakatsu, K.; Jia, Z. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)- 2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. J. Med. Chem., 2008, 51, 5943-5952.
101. Vlahakis, J.Z.; Hum, M.; Rahman, M.N.; Jia, Z.; Nakatsu, K.; Szarek, W.A. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. Bioorg. Med. Chem., 2009, 17, 2461-2475.
102. Rahman, M.N.; Vlahakis, J.Z.; Vukomanovic, D.; Szarek, W.A.; Nakatsu, K.; Jia, Z. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl] -4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. J. Med. Chem., 2009, 52, 4946-4950.
103. Roman, G.; Rahman, M.N.; Vukomanovic, D.; Jia, Z.; Nakatsu, K.; Szarek, W.A. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. Xray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone. Chem. Biol. Drug Des., 2010, 75, 68-90.
104. Rahman, M.N.; Vlahakis, J.Z.; Roman, G.; Vukomanovic, D.; Szarek, W.A.; Nakatsu, K.; Jia, Z. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors. J. Inorg. Biochem., 2010, 104, 324-330.
105. Roman, G.; Vlahakis, J.Z.; Vukomanovic, D.; Nakatsu, K.; Szarek, W.A. Heme oxygenase inhibition by 1-aryl-2-(1H-imidazol-1-yl/1H-1,2,4-triazol-1-yl) ethanones and their derivatives. ChemMedChem., 2010, 5, 1541-1555.
106. Vlahakis, J.Z.; Lazar, C.; Roman, G.; Vukomanovic, D.; Nakatsu, K.; Szarek, W.A. Heme oxygenase inhibition by α-(1H-imidazol-1-yl)-ω- phenylalkanes: effect of introduction of heteroatoms in the alkyl linker. ChemMedChem., 2012, 7, 897-902.
107. Salerno, L.; Modica, M.N.; Romeo, G.; Pittalà, V.; Siracusa, M.A.; Amato, M.E.; Acquaviva, R.; Di Giacomo, C.; Sorrenti, V. Novel inhibitors of nitric oxide synthase with antioxidant properties. Eur. J. Med. Chem., 2012, 49, 118-126.
108. Sorrenti, V.; Salerno, L.; Di Giacomo, C.; Acquaviva, R.; Siracusa, M.A.; Vanella, A. Imidazole derivatives as antioxidants and selective inhibitors of nNOS. Nitric Oxide, 2006, 14, 45-50.
109. Salerno, L.; Sorrenti, V.; Guerrera, F.; Sarvà, M.C.; Siracusa, M.A.; Di Giacomo, C.; Vanella, A. N-Substituted imidazoles as inhibitors of nitric oxide synthase. A preliminary screening. Pharmazie, 1999, 54, 685-690.
110. Sorrenti, V.; Guccione, S.; Di Giacomo, C.; Modica, M.N.; Pittalà, V.; Acquaviva, R.; Basile, L.; Pappalardo, M.; Salerno, L. Evaluation of imidazole-based compounds as heme oxygenase-1 inhibitors. Chem. Biol. Drug Des., 2012, 80, 876-886.
111. Rahman, M.N.; Vlahakis, J.Z.; Vukomanovic, D.; Lee, W.; Szarek, W.A.; Nakatsu, K.; Jia, Z. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition. PLoS One, 2012, 7, e29514.
112. Srivastava, P.; Pandey, V.C.; Misra, A.P.; Gupta, P.; Raj, K.; Bhaduri, A.P. Potential inhibitors of plasmodial heme oxygenase; an innovative approach for combating chloroquine resistant malaria. Bioorg. Med. Chem., 1998, 6, 181-187.
113. Batra, S.; Srivastava, P.; Roy, K.; Pandey, V.C.; Bhaduri, A.P. A new class of potential chloroquine-resistance reversal agents for plasmodia: syntheses and biological evaluation of 1-(3′-diethylaminopropyl)-3- (substituted phenylmethylene)pyrrolidines. J. Med. Chem., 2000, 43, 3428-3433.
114. De, D.; Bhaduri, A.P.; Milhous, W.K. A novel pyrrolidonoalkaneamine (WR 268954) that modulates chloroquine resistance of P. falciparum in vitro. Am. J. Trop. Med. Hyg., 1993, 49, 113-120.
115. Walter, R.D.; Seth, M.; Bhaduri, A.P. Reversal of chloroquine resistance in P. falciparum by CDRI 87/209 and analogues. Trop. Med. Parasitol., 1993, 44, 5-8.
116. Srivastava, P.; Pandey, V.C.; Bhaduri, A.P. Evaluation of resistantreversal, CDRI compound 87/209 and its possible mode of action in rodent experimental malaria. Trop. Med. Parasitol., 1995, 46, 83-87.
117. Barker, K.D.; Barkovits, K.; Wilks, A. Metabolic flux of extracellular heme uptake in Pseudomonas aeruginosa is driven by the ironregulated heme oxygenase (HemO). J. Biol. Chem., 2012, 287, 18342-18350.
118. Kaur, A.P.; Lansky, I.B.; Wilks, A. The role of the cytoplasmic heme-binding protein (PhuS) of pseudomonas aeruginosa in intracellular heme trafficking and iron homeostasis. J. Biol. Chem., 2009, 284, 56-66.
119. Furci, L.M.; Lopes, P.; Eakanunkul, S.; Zhong, S.; MacKerell, A.D. Jr.; Wilks, A. Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets. J. Med. Chem., 2007, 50, 3804-3813.